NM_013382.7(POMT2):c.649G>A (p.Ala217Thr) AND multiple conditions
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jan 23, 2025
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001081512.19
Allele description [Variation Report for NM_013382.7(POMT2):c.649G>A (p.Ala217Thr)]
NM_013382.7(POMT2):c.649G>A (p.Ala217Thr)
Condition(s)
- Name:
- Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
- Synonyms:
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED
- Identifiers:
- MONDO: MONDO:0013154; MedGen: C3150411; Orphanet: 588; Orphanet: 899; OMIM: 613150
- Name:
- Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 (MDDGB2)
- Synonyms:
- MUSCULAR DYSTROPHY, CONGENITAL, POMT2-RELATED; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2
- Identifiers:
- MONDO: MONDO:0013160; MedGen: C3150416; OMIM: 613156
Assertion and evidence details
Last Updated: May 16, 2025